CTNNB1 and prostate carcinoma: Research had indicated that the atypical activation of CTNNB1 was linked to the development of various types of tumors, including but not limited to colorectal cancer, ovarian cancer, prostate cancer, hepatoblastoma, and hepatocellular carcinoma (40).